Peng Lü (P Lv)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Bacillus Subtilis

Venous Thromboembolism

Top Venues

Cancer biotherapy & radiopharmaceuticals

Journal of applied microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoling Shen, Rusong Zhang, Xiaojuan Nie, Yanhua Yang, Ye Hua, Peng Lü
4-1BB Targeting Immunotherapy: Mechanism, Antibodies, and Chimeric Antigen Receptor T. Cancer biotherapy & radiopharmaceuticals (2023)
Peng Lü, Songlin Qiu, Ye Pan, Shenyan Shi, Qian Yu, Feng Yu, Lianjun Miao, Huiying Wang, Keping Chen
Discovery of an Heparin-Binding Epidermal Growth Factor Domain Antibody from a Phage Library and Analysis of Its Inhibitory Effects in SKOV3 Cells. Cancer biotherapy & radiopharmaceuticals (2021)
M Kang, F Feng, Q Ge, F Zhu, L Chen, Peng Lü, S Ma, Q Yao, Ke-Ping Chen
Display of quintuple glucagon-like peptide 1 (28-36) nonapeptide on Bacillus subtilis spore for oral administration in the treatment of type 2 diabetes. Journal of applied microbiology 130 (2) (2020)